Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PIM1 | P11309 | 1/20 | 0.76 |
| ▸ | KDM1A | O60341 | 9/20 | 0.59 |
| ▸ | LMNA | P02545 | 2/20 | 0.58 |
| ▸ | MEN1 | O00255 | 1/20 | 0.58 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.58 |
| ▸ | SIGMAR1 | Q99720 | 2/20 | 0.56 |
| ▸ | SLC22A1 | O15245 | 1/20 | 0.56 |
| ▸ | PRNP | P04156 | 1/20 | 0.56 |
| ▸ | TP53 | P04637 | 1/20 | 0.56 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.56 |
| ▸ | ADRB2 | P07550 | 1/20 | 0.56 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.56 |
| ▸ | CHRM4 | P08173 | 1/20 | 0.56 |
| ▸ | HTR1A | P08908 | 1/20 | 0.56 |
| ▸ | CHRM5 | P08912 | 1/20 | 0.56 |
| ▸ | ADRA2A | P08913 | 1/20 | 0.56 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.56 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.56 |
| ▸ | DRD2 | P14416 | 1/20 | 0.56 |
| ▸ | TSHR | P16473 | 1/20 | 0.56 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Iodide SCHEMBL31634400 | 0.98 | PIM1 (0.73) | PIM1KDM1ALMNAMEN1KMT2A | |
| Hydrochloric Acid SCHEMBL14697550 | 0.98 | PIM1 (0.73) | PIM1KDM1ALMNAMEN1KMT2A | |
| Iodide SCHEMBL31634399 | 0.98 | PIM1 (0.73) | PIM1KDM1ALMNAMEN1KMT2A | |
| SCHEMBL1649654 | 0.88 | PIM1 (0.89) | PIM1KDM1ALMNAMEN1KMT2A | |
| SCHEMBL14707051 | 0.85 | ITGB2 (0.68) | PIM1KDM1ALMNAMEN1KMT2A | |
| Hydrochloric Acid SCHEMBL14697324 | 0.84 | ITGB2 (0.67) | PIM1KDM1ALMNAMEN1KMT2A | |
| SCHEMBL10690359 | 0.83 | PIM1 (0.63) | PIM1KDM1ALMNAMEN1KMT2A | |
| SCHEMBL208025 | 0.81 | PIM1 (0.79) | PIM1KDM1ALMNAMEN1KMT2A | |
| SCHEMBL2595053 | 0.79 | LMNA (0.62) | PIM1KDM1ALMNAMEN1KMT2A | |
| SCHEMBL627548 | 0.79 | KDM1A (0.59) | PIM1KDM1ALMNAMEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 91 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-120201857-A | Method for preparing solar cell by in-situ passivation of perovskite film by using diphenylamino ammonium salt and derivative | 大连理工大学 | 2025-06-24 | — | — | CN | disclosed |
| WO-2025120367-A1 | FUSED-RING POLYCYCLIC AMINE FUNCTIONALIZED OLEFINIC POLYMERS FOR LUBRICATING OIL COMPOSITIONS | INFINEUM INTERNATIONAL LIMITED (GB) | 2025-06-12 | — | — | WO | disclosed |
| US-20250188379-A1 | FUSED-RING POLYCYCLIC AMINE FUNCTIONALIZED OLEFINIC POLYMERS FOR LUBRICATING OIL COMPOSITIONS | INFINEUM INTERNATIONAL LIMITED (GB) | 2025-06-12 | — | — | US | disclosed |
| EP-4153350-A1 | MODIFIED CLAY SORBENTS WITH MULTIFUNCTIONAL QUATERNARY AMMONIUM COMPOUNDS AND MONO-QUATERANRY AMMONIUM COMPOUNDS AND METHODS OF SORBING PER- AND POLYFLUOROALKYL SUBSTANCES (PFAS) FROM CONTAMINATED SAMPLES WITH THE MODIFIED CLAY SORBENTS | Specialty Minerals (Michigan) Inc. (US) | 2023-03-29 | — | — | EP | disclosed |
| US-9540358-B2 | Tricyclic compounds as anticancer agents | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI (US) | 2017-01-10 | — | — | US | disclosed |
| US-20140213578-A1 | TRICYCLIC COMPOUNDS AS ANTICANCER AGENTS | MT. SINAI SCHOOL OF MEDICINE (US) | 2014-07-31 | — | — | US | disclosed |
| EP-0848053-B1 | Mixtures of esterified carboxy-containing interpolymers and lubricants containing them | LUBRIZOL CORP (US) | 2010-09-29 | — | — | EP | disclosed |
| EP-1200541-B1 | NITROGEN-CONTAINING ESTERIFIED CARBOXY-CONTAINING INTERPOLYMERS HAVING ENHANCED OXIDATIVE STABILITY AND LUBRICANTS CONTAINING THEM | LUBRIZOL CORP (US) | 2010-02-10 | — | — | EP | disclosed |
| EP-0743353-B2 | Additive combinations for lubricants and functional fluids | LUBRIZOL CORP (US) | 2008-08-06 | — | — | EP | disclosed |
| EP-1326611-B1 | AZA- AND POLYAZA-NAPHTHALENYL-CARBOXAMIDES USEFUL AS HIV INTEGRASE INHIBITORS | MERCK & CO INC (US) | 2007-06-13 | — | — | EP | disclosed |
| WO-1986003221-A1 | POLYMERIC COMPOSITIONS, OIL COMPOSITIONS CONTAINING SAID POLYMERIC COMPOSITIONS, TRANSMISSION FLUIDS AND HYDRAULIC FLUIDS | THE LUBRIZOL CORPORATION (US) | 1986-06-05 | — | — | WO | disclosed |
| EP-0002286-B1 | LUBRICANT OR FUEL | ROHM AND HAAS COMPANY (US) | 1984-07-04 | — | — | EP | disclosed |
| US-4411804-A | CONTAINING GRAPHITE, MOLYBDENUM DISULFIDE, OR ZINC OXIDE AND FLOW CONTROL AGENT | ATLANTIC RICHFIELD COMPANY (US) | 1983-10-25 | — | — | US | disclosed |
| US-4292185-A | COMPRISING A DIENE-MODIFIED MONOOLEFINIC POLYMER REACTED WITH CHLOROSULFONYL ISOCYANATE AND THEN WITH AN AMINE | ROHM AND HAAS COMPANY (US) | 1981-09-29 | — | — | US | disclosed |
| US-4160739-A | Polyolefinic copolymer additives for lubricants and fuels | ROHM AND HAAS COMPANY (US) | 1979-07-10 | — | — | US | disclosed |
| EP-0002286-A2 | Lubricant or fuel | ROHM AND HAAS COMPANY (US) | 1979-06-13 | — | — | EP | disclosed |
| US-4136040-A | ALSO INCLUDING A NITROGEN CONTAINING MIXED ESTER OF AN OLEFIN ALPHA, B-UNSATURATED ACID OR ANHYDRIDE COPOLYMER | ATLANTIC RICHFIELD COMPANY (US) | 1979-01-23 | — | — | US | disclosed |
| US-4029783-A | CARDIOTONIC, VASODILATION | BOEHRINGER MANNHEIM G.M.B.H. (DT) | 1977-06-14 | — | — | US | disclosed |
| US-3998810-A | CARDIAC AND CIRCULATORY ACTIVITY | BOEHRINGER MANNHEIM G.M.B.H. (DT) | 1976-12-21 | — | — | US | disclosed |
| US-3933761-A | INTERPOLYMERS | THE LUBRIZOL CORPORATION (US) | 1976-01-20 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140213578-A1 | TRICYCLIC COMPOUNDS AS ANTICANCER AGENTS | TFEB, FOXO3, FOXO1 | PIM1 2156/4885KDM1A 2457/4885LMNA 4094/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.